IQVIA to Announce Fourth-Quarter and Full-Year 2019 Results and Issue 2020 Guidance on February 12, 2020
January 29 2020 - 4:15PM
Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), will announce its
fourth-quarter and full-year 2019 financial results and issue 2020
guidance before the market opens on Wednesday, February 12, 2020.
The IQVIA management team will also host a conference call and
webcast at 9:00 a.m. Eastern Time on that date. The earnings
release and accompanying financial information will be posted on
the IQVIA Investor Relations website at http://ir.iqvia.com.
Interested parties are invited to listen to the live event and
view the presentation slides via webcast on the IQVIA Investor
Relations website at http://ir.iqvia.com. The discussion will also
be available by dialing +1-800-672-1506 in the U.S. and Canada, or
+1-303-223-4366 for international callers.
A replay of the webcast will be available approximately two
hours after the conclusion of the live event. To access the webcast
recording, visit http://ir.iqvia.com.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced
analytics, technology solutions and contract research services to
the life sciences industry. Formed through the merger of IMS Health
and Quintiles, IQVIA applies human data science — leveraging the
analytic rigor and clarity of data science to the ever-expanding
scope of human science — to enable companies to reimagine and
develop new approaches to clinical development and
commercialization, speed innovation and accelerate improvements in
healthcare outcomes. Powered by the IQVIA CORE™, IQVIA delivers
unique and actionable insights at the intersection of large-scale
analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With approximately
65,000 employees, IQVIA conducts operations in more than 100
countries.
IQVIA is a global leader in protecting individual patient
privacy. The company uses a wide variety of privacy-enhancing
technologies and safeguards to protect individual privacy while
generating and analyzing information on a scale that helps
healthcare stakeholders identify disease patterns and correlate
with the precise treatment path and therapy needed for better
outcomes. IQVIA’s insights and execution capabilities help biotech,
medical device and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders tap
into a deeper understanding of diseases, human behaviors and
scientific advances, in an effort to advance their path toward
cures. To learn more, visit www.iqvia.com.
IQVIAFIN
Click here to subscribe to Mobile Alerts for IQVIA.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200129005513/en/
Andrew Markwick, IQVIA Investor Relations
(andrew.markwick@iqvia.com) +1.973.257.7144 Tor Constantino, IQVIA
Media Relations (tor.constantino@iqvia.com) +1.484.567.6732
IQVIA (NYSE:IQV)
Historical Stock Chart
From Mar 2024 to Apr 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Apr 2023 to Apr 2024